| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $4.5M | -22.9% |
| SG&A Expense | $4.4M | -38.9% |
| Operating Income | -$8.9M | +31.7% |
| Pre-tax Income | -$8.9M | +31.5% |
| Income Tax | $29K | -78.8% |
| Net Income | -$8.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | -10.5% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $11.3M | -12.4% |
| Total Assets | $11.8M | -10.4% |
| Current Liabilities | $1.1M | -18.6% |
| Total Liabilities | $1.4M | +0.4% |
| Stockholders' Equity | $10.4M | -11.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +41.5% |
| Capital Expenditures | $17K | -63.8% |
| Investing Cash Flow | -$17K | +83.3% |
| Financing Cash Flow | $6.0M | — |
| Free Cash Flow | -$7.3M | +41.6% |
| +32.0% |
| EPS (Basic) | $0.31 | -31.1% |
| EPS (Diluted) | $0.31 | -31.1% |